It's one of the most common strategic questions in deeptech. And most founders answer it reactively — they pursue whichever opportunity appears first, and then manage the tension as both processes run in parallel without a clear plan.
The result, in most cases, is that neither goes as well as it could have.
Fundraising and industrial partnerships are deeply interrelated processes. A signed partnership changes your fundraising story. A closed round changes your negotiating position in every partnership conversation. The sequence matters — but the right sequence is not the same for every founder in every situation. It depends on factors that most founders haven't mapped before committing to a direction.
Why the question matters more than it seems
At first glance, these appear to be two separate processes targeting two different audiences. They use different documents, different conversations, different timelines. In practice, they interact constantly — and in ways that can either compound your momentum or fragment it.
Your investors will ask about industrial traction. Your industrial partners will ask about financial runway. Both are trying to answer the same underlying question from different angles: is this startup viable, and is it worth committing resources to?
A founder running both processes simultaneously is managing two narratives with different — sometimes conflicting — logics. The fundraising narrative emphasises scale and market potential. The industrial partnership narrative emphasises specific problem-solving and operational fit. Letting them bleed into each other in either direction costs deals. Sequencing them thoughtfully prevents that.
Scenario 1: Industrial partnership first
This is the right choice when your technology is at a stage where a validated proof of concept with an industrial partner is more strategically valuable than additional runway — and when you have a live, credible conversation already in progress.
A signed partnership changes your fundraising conversation in ways that are difficult to overstate. It de-risks the investment thesis for every investor you approach. It signals that a sophisticated industrial player — one with far more domain knowledge than any VC — has evaluated your technology and committed real resources to it. It replaces "we believe there is a market" with "a major player in that market is already paying us to develop this." That shift is worth months of investor conversations.
In biotech specifically, a sponsored research agreement with a major pharmaceutical company is not merely commercial progress. It is a signal that fundamentally reshapes the risk profile of the investment — reducing the market validation risk that is otherwise the dominant concern at early stages.
The trap in this scenario is timeline. Industrial partnership conversations are slow — often 6 to 18 months from first serious contact to a signed agreement, even when both parties are genuinely motivated. Pursuing partnership first requires runway. If you are operating on 4 months of cash, partnership-first is not a strategic sequence. It is a race you will lose.
This scenario works when: you have 12+ months of runway, an active and progressing conversation with a credible industrial partner, and clear signal that the partnership is likely to close before you need to raise.
Scenario 2: Fundraising first
This is the right choice when you need runway to pursue industrial conversations from a position of strength — and when your current financial situation is already weakening your negotiating position in ways you may not fully see.
Industrial buyers sense financial pressure. It is more visible than founders realise. A founder who is clearly running out of money negotiates every partnership term differently — they cannot afford to walk away from a bad exclusivity clause, cannot take the time a complex negotiation deserves, cannot hold firm on IP scope when their bank account is running low. Fundraising first, when you can execute it, gives you the runway to negotiate properly. It also gives you something more subtle: the composure to have patient, unhurried conversations.
A closed round also functions as a credibility signal with industrial players who wouldn't have taken the meeting with a pre-seed startup. "We've just closed a seed round from [relevant investor]" communicates financial sustainability, external validation, and a functioning company — all of which reduce the perceived risk of engaging with you.
The trap here is using fundraising as a substitute for commercial work. Many founders raise a round, extend their runway by 18 months, and then restart the industrial conversation from zero — having made no commercial progress during the fundraising process, because fundraising consumed all available attention. The round buys time. It does not close deals, build relationships, or validate use cases. Those still require deliberate work, in parallel or immediately after.
This scenario works when: you have less than 6 months of runway, you have strong investor interest and a clear story to tell, and you need the round to credibly pursue the industrial conversations that matter most.
Scenario 3: Parallel tracks
This is the reality for most founders — and the most complex to manage well. Running fundraising and industrial partnerships simultaneously is not inherently wrong. It is simply demanding in ways that are easy to underestimate.
It requires maintaining two coherent, distinct narratives for two different audiences, while allocating founder time across two processes that each deserve full attention and are each sensitive to distraction and delay. The founders who manage this well share one discipline: they are explicit about the relationship between the two processes — with themselves, with their team, and with their interlocutors.
With investors: "We have an active industrial partnership conversation we expect to conclude by [date], and this round gives us the runway to see it through and negotiate from strength." With industrial partners: "We are closing a funding round that extends our runway through [date], which means we can commit to the collaboration timeline you need." In both cases, each process reinforces the credibility of the other — but only if you frame them that way deliberately.
The trap is letting the two processes bleed into each other. Using the investor pitch logic in industrial meetings. Letting runway anxiety drive you to accept partnership terms you shouldn't. Conflating the timelines in ways that create pressure where there shouldn't be any. The founders who run parallel tracks successfully treat them as genuinely separate processes, with separate documents, separate narratives, and separate pacing — coordinated at the strategic level, kept distinct at the execution level.
A practical framework for deciding
Before committing to a sequence, answer four questions honestly.
How much runway do you have? Less than 6 months means fundraising is your immediate priority. More than 18 months means you can afford to let the partnership conversation develop at the pace it requires.
Where is your most advanced industrial conversation? If you have a live, progressing conversation with a credible partner that is 3 to 4 months from a possible signature, that conversation should not be interrupted by a fundraising process that pulls your attention. If you have no active industrial conversations, partnership-first is a strategy for a situation you haven't yet created.
What does closing a partnership do for your fundraising story? At some stages — particularly pre-seed and seed — a signed industrial collaboration is transformative for investor conversations. At later stages — Series B and beyond — investors may care less about a single partnership and more about a pattern of commercial traction. Know what your specific investors are looking for at your specific stage.
What is your current negotiating position? Desperation is visible in both processes and it compounds in both. The sequence that keeps you in the strongest position across both conversations — financially, relationally, and strategically — is the right one. There is no formula that works without that assessment.
There is no universal right answer. But the founders who answer these four questions deliberately — before either process starts, not in the middle of both — consistently make better decisions, avoid the worst traps, and close both faster than those who let circumstance decide the sequence for them.